Related Experiment Video

Updated: Aug 27, 2025

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.5K

HDL metabolism and functions impacting on cell cholesterol homeostasis are specifically altered in patients with

Maria Pia Adorni1, Marcella Palumbo2, Cinzia Marchi2

  • 1Department of Medicine and Surgery, Unit of Neuroscience, University of Parma, Via Volturno 39/F, Parma, Italy.

Frontiers in Immunology
|September 29, 2022
PubMed

Insights

Abdominal aortic aneurysm (AAA) patients show altered high-density lipoprotein (HDL) metabolism, impacting anti-inflammatory and repair functions. These findings suggest new diagnostic and therapeutic targets for AAA management.

Area of Science:

  • Vascular Biology
  • Lipid Metabolism
  • Atherosclerosis Research

Background:

  • Abdominal aortic aneurysm (AAA) pathogenesis involves vascular inflammation and matrix metalloproteinase activation.
  • Lipoproteins influence tissue inflammation and repair by regulating intracellular cholesterol.
  • Excess intracellular cholesterol can lead to cell damage and pro-inflammatory responses.

Purpose of the Study:

  • To investigate lipoprotein metabolism and function in AAA patients.
  • To identify potential non-atherosclerosis-specific abnormalities in AAA.
  • To compare lipoprotein profiles in AAA versus control vasculopathic patients.

Main Methods:

  • Measured serum lecithin-cholesterol acyltransferase (LCAT) and cholesteryl ester transfer protein (CETP) activity.
  • Assessed high-density lipoprotein (HDL)-cholesterol efflux capacity (CEC) via ATP-binding cassette G1 (ABCG1) and A1 (ABCA1) pathways.
  • Determined serum cell cholesterol loading capacity (CLC) using radioisotopic and fluorimetric methods.

Main Results:

  • AAA patients exhibited significantly higher LCAT and CETP activity compared to controls.
  • HDL ABCG1-mediated cholesterol efflux capacity was reduced, while ABCA1-mediated efflux was increased in AAA.
  • Cholesterol efflux capacity and CETP activity correlated with cholesterol loading capacity exclusively in AAA patients.

Conclusions:

  • AAA patients display altered HDL metabolism and function, affecting anti-inflammatory and tissue repair capabilities.
  • The ABCG1-related intracellular signaling pathway appears particularly relevant in AAA.
  • Further research could lead to novel diagnostic markers and therapeutic strategies for early AAA management.
Abstract

Keywords:
ABCA1ABCG1arterial aneurysmcholesterol effluxcholesteryl ester transfer proteininflammationlecithin cholesterol acyltransferasevascular biology

More Related Videos

Imaging and Analysis of Oil Red O-Stained Whole Aorta Lesions in an Aneurysm Hyperlipidemia Mouse Model07:57

Imaging and Analysis of Oil Red O-Stained Whole Aorta Lesions in an Aneurysm Hyperlipidemia Mouse Model

Published on: May 2, 2022

13.5K
High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay08:18

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay

Published on: January 7, 2019

9.1K

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
647
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
24
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
44
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
47
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.2K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
25